GI & Endoscopy

According to Zion Research, the future of the gastrointestinal endoscopic device market has $8.5 billion in sight, Net Dug Out reports.

Osaka, Japan-based Takeda Pharmaceutical and the New York Academy of Sciences have established the Takeda Innovators in Science Award.

Researchers from Queen's University in Belfast, Ireland believe they've found a way to bypass bowel cancers defense against cetuximab, Science Daily reports.

American Gastroenterological Association Institute and North American Center for Continuing Medical Education have developed an educational presentation about inflammatory bowel disease, titled "Advancing IBD Practice in Our Communities."

Here are six updates on gastroenterology and endoscopy companies.

Residents of Montreal will have to wait longer for colonoscopies after Cliniques d'endoscopie du Quebec closed 11 private clinics throughout the province, CBCNews Montreal reports.

Laval, Canada-based Valeant Pharmaceuticals is entering a free fall, Business Insider reports.

Charles Barish, MD, is a gastroenterologist at Raleigh, N.C.-based Wake Gastroenterology.

A study in Cancer Medicine found that a new blood test is more sensitive than a standard carcinoembryonic antigen test when identifying colorectal cancer recurrence.

Peyton P. Berookim, MD, is a gastroenterologist and the director of the Los Angeles-based Gastroenterology Institute of Southern California.